Dr Shawn Johnston, MD | |
3801 University Lake Dr, Anchorage, AK 99508-4639 | |
(907) 563-8876 | |
(907) 762-6315 |
Full Name | Dr Shawn Johnston |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 29 Years |
Location | 3801 University Lake Dr, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699746941 | NPI | - | NPPES |
MD9202 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 4332 (Alaska) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aa Pain Clinic, Inc. | 7911892443 | 10 |
News Archive
A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.
› Verified 8 days ago
Entity Name | Rehabilitation Medicine Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831194562 PECOS PAC ID: 1456265578 Enrollment ID: O20031113000531 |
News Archive
A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.
› Verified 8 days ago
Entity Name | Aa Pain Clinic, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972596633 PECOS PAC ID: 7911892443 Enrollment ID: O20040216000359 |
News Archive
A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.
› Verified 8 days ago
Entity Name | Alaska Spine & Pain Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922338854 PECOS PAC ID: 6507189479 Enrollment ID: O20141229001603 |
News Archive
A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shawn Johnston, MD 4100 Lake Otis Pkwy, Ste 216, Anchorage, AK 99508-5230 Ph: (907) 563-2873 | Dr Shawn Johnston, MD 3801 University Lake Dr, Anchorage, AK 99508-4639 Ph: (907) 563-8876 |
News Archive
A recent analysis from Canada found that information on health-related quality of life is often not collected for investigational cancer drugs or used to calculate the balance of costs and benefits of these drugs when they are submitted for reimbursement, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.
› Verified 8 days ago
Dr. Michael James, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3801 University Lake Dr, Anchorage, AK 99508 Phone: 907-563-8876 Fax: 907-762-6315 | |
Jared Robert Kirkham, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Otis Pkwy Ste 108, Anchorage, AK 99508 Phone: 907-563-3145 Fax: 833-464-5196 | |
Jennifer Lynn Andress, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 11260 Old Seward Hwy, Anchorage, AK 99515 Phone: 907-341-5555 | |
Erik Marshall Kussro, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3831 Piper St, Suite S450, Anchorage, AK 99508 Phone: 907-258-6999 Fax: 907-258-9470 | |
Jessica Marie Quinn, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1389 Huffman Park Dr Ste 140, Anchorage, AK 99515 Phone: 907-222-6122 | |
Crystal Marie Daniken, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9100 Centennial Cir, Anchorage, AK 99504 Phone: 907-333-8100 | |
Gail French, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1413 G St, Anchorage, AK 99501 Phone: 907-344-6261 |